Cargando…
The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437299/ https://www.ncbi.nlm.nih.gov/pubmed/36059708 http://dx.doi.org/10.3389/fonc.2022.953933 |
_version_ | 1784781571902930944 |
---|---|
author | Harrison, Ariel C. Kanwal, Fasiha Asrani, Sumeet K. Thrift, Aaron P. Amos, Chris I. Jibaja-Weiss, Maria L. Montealegre, Jane R. Hwang, Jessica P. Singal, Amit G. El-Serag, Hashem B. |
author_facet | Harrison, Ariel C. Kanwal, Fasiha Asrani, Sumeet K. Thrift, Aaron P. Amos, Chris I. Jibaja-Weiss, Maria L. Montealegre, Jane R. Hwang, Jessica P. Singal, Amit G. El-Serag, Hashem B. |
author_sort | Harrison, Ariel C. |
collection | PubMed |
description | Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030. |
format | Online Article Text |
id | pubmed-9437299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94372992022-09-03 The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy Harrison, Ariel C. Kanwal, Fasiha Asrani, Sumeet K. Thrift, Aaron P. Amos, Chris I. Jibaja-Weiss, Maria L. Montealegre, Jane R. Hwang, Jessica P. Singal, Amit G. El-Serag, Hashem B. Front Oncol Oncology Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030. Frontiers Media S.A. 2022-08-19 /pmc/articles/PMC9437299/ /pubmed/36059708 http://dx.doi.org/10.3389/fonc.2022.953933 Text en Copyright © 2022 Harrison, Kanwal, Asrani, Thrift, Amos, Jibaja-Weiss, Montealegre, Hwang, Singal and El-Serag https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Harrison, Ariel C. Kanwal, Fasiha Asrani, Sumeet K. Thrift, Aaron P. Amos, Chris I. Jibaja-Weiss, Maria L. Montealegre, Jane R. Hwang, Jessica P. Singal, Amit G. El-Serag, Hashem B. The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy |
title | The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy |
title_full | The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy |
title_fullStr | The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy |
title_full_unstemmed | The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy |
title_short | The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy |
title_sort | texas collaborative center for hepatocellular cancer: reducing liver cancer mortality in texas through coordination, collaboration and advocacy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437299/ https://www.ncbi.nlm.nih.gov/pubmed/36059708 http://dx.doi.org/10.3389/fonc.2022.953933 |
work_keys_str_mv | AT harrisonarielc thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT kanwalfasiha thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT asranisumeetk thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT thriftaaronp thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT amoschrisi thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT jibajaweissmarial thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT montealegrejaner thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT hwangjessicap thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT singalamitg thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT elseraghashemb thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT harrisonarielc texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT kanwalfasiha texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT asranisumeetk texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT thriftaaronp texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT amoschrisi texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT jibajaweissmarial texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT montealegrejaner texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT hwangjessicap texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT singalamitg texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy AT elseraghashemb texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy |